onenewsnow | How did he know this? Because of
research done by the National Institutes of Health, of which he is the
director. In connection with the SARS outbreak - caused by a coronavirus
dubbed SARS- CoV - the NIH researched chloroquine and concluded that it
was effective at stopping the SARS coronavirus in its tracks. The
COVID-19 bug is likewise a coronavirus, labeled SARS-CoV-2. While not
exactly the same virus as SARS-CoV-1, it is genetically related to it,
and shares 79% of its genome, as the name SARS-CoV-2 implies. They both
use the same host cell receptor, which is what viruses use to gain entry
to the cell and infect the victim.
The Virology Journal - the official publication of Dr. Fauci’s National Institutes of Health - published what is now a blockbuster article on August 22, 2005, under the heading - get ready for this - “Chloroquine is a potent inhibitor of SARS coronavirus infection and spread.” (Emphasis
mine throughout.) Write the researchers, “We report...that chloroquine
has strong antiviral effects on SARS-CoV infection of primate cells.
These inhibitory effects are observed when the cells are treated with
the drug either before or after exposure to the virus, suggesting both prophylactic and therapeutic advantage.”
This means, of course, that Dr. Fauci (pictured at right)
has known for 15 years that chloroquine and it’s even milder derivative
hydroxychloroquine (HCQ) will not only treat a current case of
coronavirus (“therapeutic”) but prevent future cases (“prophylactic”).
So HCQ functions as both a cure and a vaccine. In other words, it’s a wonder drug for coronavirus. Said Dr. Fauci’s NIH in 2005, “concentrations of 10 μM completely abolished SARS-CoV infection.” Fauci’s researchers add, “chloroquine can effectively reduce the establishment of infection and spread of SARS-CoV.”
Dr. Didier Raoult, the Anthony Fauci of France, had such spectacular
success using HCQ to treat victims of SARS-CoV-2 that he said way back
on February 25 that “it’s game over” for coronavirus.
He and a team of researchers reported
that the use of HCQ administered with both azithromycin and zinc cured
79 of 80 patients with only “rare and minor” adverse events. “In
conclusion,” these researchers write, “we confirm the efficacy of
hydroxychloroquine associated with azithromycin in the treatment of
COVID-19 and its potential effectiveness in the early impairment of
contagiousness.”
0 comments:
Post a Comment